サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1120808

世界の免疫腫瘍アッセイ市場：考察と予測 (2028年まで)

Global Immuno Oncology Assays Market Insights, Forecast to 2028
出版日: | 発行: QYResearch | ページ情報: 英文 96 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
世界の免疫腫瘍アッセイ市場：考察と予測 (2028年まで)
出版日: 2022年08月31日
発行: QYResearch
ページ情報: 英文 96 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、免疫腫瘍アッセイ (Immuno Oncology Assays) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析：タイプ別
    • 世界の免疫腫瘍アッセイの市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
    • Immunoassay
    • Flow Cytometry
    • PCR
    • Next Generation Sequencing
  • 市場：アプリケーション別
    • 世界の免疫腫瘍アッセイの市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
    • Research
    • Clinical Diagnostics
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の免疫腫瘍アッセイの市場展望 (2017-2028)
  • 免疫腫瘍アッセイの市場成長トレンド：地域別
    • 免疫腫瘍アッセイ 市場規模：地域別: 2017 VS 2021 VS 2028
    • 免疫腫瘍アッセイの市場規模実績：地域別 (2017-2022)
    • 免疫腫瘍アッセイの市場規模予測：地域別 (2023-2028)
  • 免疫腫瘍アッセイ 市場動向
    • 免疫腫瘍アッセイ 業界動向
    • 免疫腫瘍アッセイ 市場の促進要因
    • 免疫腫瘍アッセイ 市場の課題
    • 免疫腫瘍アッセイ 市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界の免疫腫瘍アッセイの上位企業：収益別
    • 世界の免疫腫瘍アッセイの上位企業：収益別 (2017-2022)
    • 世界の免疫腫瘍アッセイの収益シェア：企業別 (2017-2022)
  • 世界の免疫腫瘍アッセイの市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 企業ランキング：免疫腫瘍アッセイの収益
  • 世界の免疫腫瘍アッセイ 市場集中度
    • 世界の免疫腫瘍アッセイ 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： 免疫腫瘍アッセイの収益 2021
  • 免疫腫瘍アッセイの主要企業の本社および事業エリア
  • 主要企業 免疫腫瘍アッセイの製品ソリューションおよびサービス
  • 市場参入時期： 免疫腫瘍アッセイ 市場
  • M&A, 拡張計画

第4章 免疫腫瘍アッセイ 内訳データ：タイプ別

  • 世界の免疫腫瘍アッセイの市場規模実績：タイプ別 (2017-2022)
  • 世界の免疫腫瘍アッセイの市場規模予測：タイプ別 (2023-2028)

第5章 免疫腫瘍アッセイ 内訳データ：アプリケーション別

  • 世界の免疫腫瘍アッセイの市場規模実績：アプリケーション別 (2017-2022)
  • 世界の免疫腫瘍アッセイの市場規模予測：アプリケーション別 (2023-2028)

第6章 北米

  • 北米の免疫腫瘍アッセイ 市場規模 (2017-2028)
  • 北米の免疫腫瘍アッセイ 市場規模：タイプ別
    • 北米の免疫腫瘍アッセイ 市場規模：タイプ別 (2017-2022)
    • 北米の免疫腫瘍アッセイ 市場規模：タイプ別 (2023-2028)
    • 北米の免疫腫瘍アッセイの市場シェア：タイプ別 (2017-2028)
  • 北米の免疫腫瘍アッセイ 市場規模：アプリケーション別
    • 北米の免疫腫瘍アッセイ 市場規模：アプリケーション別 (2017-2022)
    • 北米の免疫腫瘍アッセイ 市場規模：アプリケーション別 (2023-2028)
    • 北米の免疫腫瘍アッセイの市場シェア：アプリケーション別 (2017-2028)
  • 北米の免疫腫瘍アッセイ 市場規模：国別
    • 北米の免疫腫瘍アッセイ 市場規模：国別 (2017-2022)
    • 北米の免疫腫瘍アッセイ 市場規模：国別 (2023-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の免疫腫瘍アッセイ 市場規模 (2017-2028)
  • 欧州の免疫腫瘍アッセイ 市場規模：タイプ別
    • 欧州の免疫腫瘍アッセイ 市場規模：タイプ別 (2017-2022)
    • 欧州の免疫腫瘍アッセイ 市場規模：タイプ別 (2023-2028)
    • 欧州の免疫腫瘍アッセイの市場シェア：タイプ別 (2017-2028)
  • 欧州の免疫腫瘍アッセイ 市場規模：アプリケーション別
    • 欧州の免疫腫瘍アッセイ 市場規模：アプリケーション別 (2017-2022)
    • 欧州の免疫腫瘍アッセイ 市場規模：アプリケーション別 (2023-2028)
    • 欧州の免疫腫瘍アッセイの市場シェア：アプリケーション別 (2017-2028)
  • 欧州の免疫腫瘍アッセイ 市場規模：国別
    • 欧州の免疫腫瘍アッセイ 市場規模：国別 (2017-2022)
    • 欧州の免疫腫瘍アッセイ 市場規模：国別 (2023-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 アジア太平洋地域

  • アジア太平洋地域 免疫腫瘍アッセイ 市場規模 (2017-2028)
  • アジア太平洋地域 免疫腫瘍アッセイ 市場規模：タイプ別
    • アジア太平洋地域 免疫腫瘍アッセイ 市場規模：タイプ別 (2017-2022)
    • アジア太平洋地域 免疫腫瘍アッセイ 市場規模：タイプ別 (2023-2028)
    • アジア太平洋地域 免疫腫瘍アッセイの市場シェア：タイプ別 (2017-2028)
  • アジア太平洋地域 免疫腫瘍アッセイ 市場規模：アプリケーション別
    • アジア太平洋地域 免疫腫瘍アッセイ 市場規模：アプリケーション別 (2017-2022)
    • アジア太平洋地域 免疫腫瘍アッセイ 市場規模：アプリケーション別 (2023-2028)
    • アジア太平洋地域 免疫腫瘍アッセイの市場シェア：アプリケーション別 (2017-2028)
  • アジア太平洋地域 免疫腫瘍アッセイ 市場規模：地域別
    • アジア太平洋地域 免疫腫瘍アッセイ 市場規模：地域別 (2017-2022)
    • アジア太平洋地域 免疫腫瘍アッセイ 市場規模：地域別 (2023-2028)
    • 中国
    • 日本
    • 韓国
    • 東南アジア
    • インド
    • オーストラリア

第9章 ラテンアメリカ

  • ラテンアメリカの免疫腫瘍アッセイ 市場規模 (2017-2028)
  • ラテンアメリカの免疫腫瘍アッセイ 市場規模：タイプ別
    • ラテンアメリカの免疫腫瘍アッセイ 市場規模：タイプ別 (2017-2022)
    • ラテンアメリカの免疫腫瘍アッセイ 市場規模：タイプ別 (2023-2028)
    • ラテンアメリカの免疫腫瘍アッセイの市場シェア：タイプ別 (2017-2028)
  • ラテンアメリカの免疫腫瘍アッセイ 市場規模：アプリケーション別
    • ラテンアメリカの免疫腫瘍アッセイ 市場規模：アプリケーション別 (2017-2022)
    • ラテンアメリカの免疫腫瘍アッセイ 市場規模：アプリケーション別 (2023-2028)
    • ラテンアメリカの免疫腫瘍アッセイの市場シェア：アプリケーション別 (2017-2028)
  • ラテンアメリカの免疫腫瘍アッセイ 市場規模：国別
    • ラテンアメリカの免疫腫瘍アッセイ 市場規模：国別 (2017-2022)
    • ラテンアメリカの免疫腫瘍アッセイ 市場規模：国別 (2023-2028)
    • メキシコ
    • ブラジル

第10章 中東・アフリカ

  • 中東・アフリカの免疫腫瘍アッセイ 市場規模 (2017-2028)
  • 中東・アフリカの免疫腫瘍アッセイ 市場規模：タイプ別
    • 中東・アフリカの免疫腫瘍アッセイ 市場規模：タイプ別 (2017-2022)
    • 中東・アフリカの免疫腫瘍アッセイ 市場規模：タイプ別 (2023-2028)
    • 中東・アフリカの免疫腫瘍アッセイの市場シェア：タイプ別 (2017-2028)
  • 中東・アフリカの免疫腫瘍アッセイ 市場規模：アプリケーション別
    • 中東・アフリカの免疫腫瘍アッセイ 市場規模：アプリケーション別 (2017-2022)
    • 中東・アフリカの免疫腫瘍アッセイ 市場規模：アプリケーション別 (2023-2028)
    • 中東・アフリカの免疫腫瘍アッセイの市場シェア：アプリケーション別 (2017-2028)
  • 中東・アフリカの免疫腫瘍アッセイ 市場規模：国別
    • 中東・アフリカの免疫腫瘍アッセイ 市場規模：国別 (2017-2022)
    • 中東・アフリカの免疫腫瘍アッセイ 市場規模：国別 (2023-2028)
    • トルコ
    • サウジアラビア
    • UAE

第11章 主要企業のプロファイル

  • Thermo Fischer Scientific
  • Roche Diagnostics
  • Agilent Technologies
  • Illumina

第12章 アナリストによる分析/結論

第13章 付録

図表
  • Table 1. Global Immuno Oncology Assays Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Immunoassay
  • Table 3. Key Players of Flow Cytometry
  • Table 4. Key Players of PCR
  • Table 5. Key Players of Next Generation Sequencing
  • Table 6. Global Immuno Oncology Assays Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 7. Global Immuno Oncology Assays Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 8. Global Immuno Oncology Assays Market Size by Region (2017-2022) & (US$ Million)
  • Table 9. Global Immuno Oncology Assays Market Share by Region (2017-2022)
  • Table 10. Global Immuno Oncology Assays Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 11. Global Immuno Oncology Assays Market Share by Region (2023-2028)
  • Table 12. Immuno Oncology Assays Market Trends
  • Table 13. Immuno Oncology Assays Market Drivers
  • Table 14. Immuno Oncology Assays Market Challenges
  • Table 15. Immuno Oncology Assays Market Restraints
  • Table 16. Global Immuno Oncology Assays Revenue by Players (2017-2022) & (US$ Million)
  • Table 17. Global Immuno Oncology Assays Revenue Share by Players (2017-2022)
  • Table 18. Global Top Immuno Oncology Assays by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno Oncology Assays as of 2021)
  • Table 19. Ranking of Global Top Immuno Oncology Assays Companies by Revenue (US$ Million) in 2021
  • Table 20. Global 5 Largest Players Market Share by Immuno Oncology Assays Revenue (CR5 and HHI) & (2017-2022)
  • Table 21. Key Players Headquarters and Area Served
  • Table 22. Key Players Immuno Oncology Assays Product Solution and Service
  • Table 23. Date of Enter into Immuno Oncology Assays Market
  • Table 24. Mergers & Acquisitions, Expansion Plans
  • Table 25. Global Immuno Oncology Assays Market Size by Type (2017-2022) & (US$ Million)
  • Table 26. Global Immuno Oncology Assays Revenue Market Share by Type (2017-2022)
  • Table 27. Global Immuno Oncology Assays Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 28. Global Immuno Oncology Assays Revenue Market Share by Type (2023-2028)
  • Table 29. Global Immuno Oncology Assays Market Size by Application (2017-2022) & (US$ Million)
  • Table 30. Global Immuno Oncology Assays Revenue Share by Application (2017-2022)
  • Table 31. Global Immuno Oncology Assays Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 32. Global Immuno Oncology Assays Revenue Share by Application (2023-2028)
  • Table 33. North America Immuno Oncology Assays Market Size by Type (2017-2022) & (US$ Million)
  • Table 34. North America Immuno Oncology Assays Market Size by Type (2023-2028) & (US$ Million)
  • Table 35. North America Immuno Oncology Assays Market Size by Application (2017-2022) & (US$ Million)
  • Table 36. North America Immuno Oncology Assays Market Size by Application (2023-2028) & (US$ Million)
  • Table 37. North America Immuno Oncology Assays Market Size by Country (2017-2022) & (US$ Million)
  • Table 38. North America Immuno Oncology Assays Market Size by Country (2023-2028) & (US$ Million)
  • Table 39. Europe Immuno Oncology Assays Market Size by Type (2017-2022) & (US$ Million)
  • Table 40. Europe Immuno Oncology Assays Market Size by Type (2023-2028) & (US$ Million)
  • Table 41. Europe Immuno Oncology Assays Market Size by Application (2017-2022) & (US$ Million)
  • Table 42. Europe Immuno Oncology Assays Market Size by Application (2023-2028) & (US$ Million)
  • Table 43. Europe Immuno Oncology Assays Market Size by Country (2017-2022) & (US$ Million)
  • Table 44. Europe Immuno Oncology Assays Market Size by Country (2023-2028) & (US$ Million)
  • Table 45. Asia Pacific Immuno Oncology Assays Market Size by Type (2017-2022) & (US$ Million)
  • Table 46. Asia Pacific Immuno Oncology Assays Market Size by Type (2023-2028) & (US$ Million)
  • Table 47. Asia Pacific Immuno Oncology Assays Market Size by Application (2017-2022) & (US$ Million)
  • Table 48. Asia Pacific Immuno Oncology Assays Market Size by Application (2023-2028) & (US$ Million)
  • Table 49. Asia Pacific Immuno Oncology Assays Market Size by Region (2017-2022) & (US$ Million)
  • Table 50. Asia Pacific Immuno Oncology Assays Market Size by Region (2023-2028) & (US$ Million)
  • Table 51. Latin America Immuno Oncology Assays Market Size by Type (2017-2022) & (US$ Million)
  • Table 52. Latin America Immuno Oncology Assays Market Size by Type (2023-2028) & (US$ Million)
  • Table 53. Latin America Immuno Oncology Assays Market Size by Application (2017-2022) & (US$ Million)
  • Table 54. Latin America Immuno Oncology Assays Market Size by Application (2023-2028) & (US$ Million)
  • Table 55. Latin America Immuno Oncology Assays Market Size by Country (2017-2022) & (US$ Million)
  • Table 56. Latin America Immuno Oncology Assays Market Size by Country (2023-2028) & (US$ Million)
  • Table 57. Middle East and Africa Immuno Oncology Assays Market Size by Type (2017-2022) & (US$ Million)
  • Table 58. Middle East and Africa Immuno Oncology Assays Market Size by Type (2023-2028) & (US$ Million)
  • Table 59. Middle East and Africa Immuno Oncology Assays Market Size by Application (2017-2022) & (US$ Million)
  • Table 60. Middle East and Africa Immuno Oncology Assays Market Size by Application (2023-2028) & (US$ Million)
  • Table 61. Middle East and Africa Immuno Oncology Assays Market Size by Country (2017-2022) & (US$ Million)
  • Table 62. Middle East and Africa Immuno Oncology Assays Market Size by Country (2023-2028) & (US$ Million)
  • Table 63. Thermo Fischer Scientific Company Details
  • Table 64. Thermo Fischer Scientific Business Overview
  • Table 65. Thermo Fischer Scientific Immuno Oncology Assays Product
  • Table 66. Thermo Fischer Scientific Revenue in Immuno Oncology Assays Business (2017-2022) & (US$ Million)
  • Table 67. Thermo Fischer Scientific Recent Developments
  • Table 68. Roche Diagnostics Company Details
  • Table 69. Roche Diagnostics Business Overview
  • Table 70. Roche Diagnostics Immuno Oncology Assays Product
  • Table 71. Roche Diagnostics Revenue in Immuno Oncology Assays Business (2017-2022) & (US$ Million)
  • Table 72. Roche Diagnostics Recent Developments
  • Table 73. Agilent Technologies Company Details
  • Table 74. Agilent Technologies Business Overview
  • Table 75. Agilent Technologies Immuno Oncology Assays Product
  • Table 76. Agilent Technologies Revenue in Immuno Oncology Assays Business (2017-2022) & (US$ Million)
  • Table 77. Agilent Technologies Recent Developments
  • Table 78. Illumina Company Details
  • Table 79. Illumina Business Overview
  • Table 80. Illumina Immuno Oncology Assays Product
  • Table 81. Illumina Revenue in Immuno Oncology Assays Business (2017-2022) & (US$ Million)
  • Table 82. Illumina Recent Developments
  • Table 83. Research Programs/Design for This Report
  • Table 84. Key Data Information from Secondary Sources
  • Table 85. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Immuno Oncology Assays Market Share by Type: 2021 VS 2028
  • Figure 2. Immunoassay Features
  • Figure 3. Flow Cytometry Features
  • Figure 4. PCR Features
  • Figure 5. Next Generation Sequencing Features
  • Figure 6. Global Immuno Oncology Assays Market Share by Application: 2021 VS 2028
  • Figure 7. Research Case Studies
  • Figure 8. Clinical Diagnostics Case Studies
  • Figure 9. Immuno Oncology Assays Report Years Considered
  • Figure 10. Global Immuno Oncology Assays Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 11. Global Immuno Oncology Assays Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 12. Global Immuno Oncology Assays Market Share by Region: 2021 VS 2028
  • Figure 13. Global Immuno Oncology Assays Market Share by Players in 2021
  • Figure 14. Global Top Immuno Oncology Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno Oncology Assays as of 2021)
  • Figure 15. The Top 10 and 5 Players Market Share by Immuno Oncology Assays Revenue in 2021
  • Figure 16. North America Immuno Oncology Assays Market Size YoY (2017-2028) & (US$ Million)
  • Figure 17. North America Immuno Oncology Assays Market Size Market Share by Type (2017-2028)
  • Figure 18. North America Immuno Oncology Assays Market Size Market Share by Application (2017-2028)
  • Figure 19. North America Immuno Oncology Assays Market Size Share by Country (2017-2028)
  • Figure 20. United States Immuno Oncology Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 21. Canada Immuno Oncology Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 22. Europe Immuno Oncology Assays Market Size YoY (2017-2028) & (US$ Million)
  • Figure 23. Europe Immuno Oncology Assays Market Size Market Share by Type (2017-2028)
  • Figure 24. Europe Immuno Oncology Assays Market Size Market Share by Application (2017-2028)
  • Figure 25. Europe Immuno Oncology Assays Market Size Share by Country (2017-2028)
  • Figure 26. Germany Immuno Oncology Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 27. France Immuno Oncology Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 28. U.K. Immuno Oncology Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. Italy Immuno Oncology Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. Russia Immuno Oncology Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Nordic Countries Immuno Oncology Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Asia-Pacific Immuno Oncology Assays Market Size YoY (2017-2028) & (US$ Million)
  • Figure 33. Asia Pacific Immuno Oncology Assays Market Size Market Share by Type (2017-2028)
  • Figure 34. Asia Pacific Immuno Oncology Assays Market Size Market Share by Application (2017-2028)
  • Figure 35. Asia Pacific Immuno Oncology Assays Market Size Share by Region (2017-2028)
  • Figure 36. China Immuno Oncology Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 37. Japan Immuno Oncology Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 38. South Korea Immuno Oncology Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. Southeast Asia Immuno Oncology Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. India Immuno Oncology Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. Australia Immuno Oncology Assays Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

  • Figure 42. Latin America Immuno Oncology Assays Market Size YoY (2017-2028) & (US$ Million)
  • Figure 43. Latin America Immuno Oncology Assays Market Size Market Share by Type (2017-2028)
  • Figure 44. Latin America Immuno Oncology Assays Market Size Market Share by Application (2017-2028)
  • Figure 45. Latin America Immuno Oncology Assays Market Size Share by Country (2017-2028)
  • Figure 46. Mexico Immuno Oncology Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 47. Brazil Immuno Oncology Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 48. Middle East & Africa Immuno Oncology Assays Market Size YoY (2017-2028) & (US$ Million)
  • Figure 49. Middle East and Africa Immuno Oncology Assays Market Size Market Share by Type (2017-2028)
  • Figure 50. Middle East and Africa Immuno Oncology Assays Market Size Market Share by Application (2017-2028)
  • Figure 51. Middle East and Africa Immuno Oncology Assays Market Size Share by Country (2017-2028)
  • Figure 52. Turkey Immuno Oncology Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 53. Saudi Arabia Immuno Oncology Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 54. UAE Immuno Oncology Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 55. Thermo Fischer Scientific Revenue Growth Rate in Immuno Oncology Assays Business (2017-2022)
  • Figure 56. Roche Diagnostics Revenue Growth Rate in Immuno Oncology Assays Business (2017-2022)
  • Figure 57. Agilent Technologies Revenue Growth Rate in Immuno Oncology Assays Business (2017-2022)
  • Figure 58. Illumina Revenue Growth Rate in Immuno Oncology Assays Business (2017-2022)
  • Figure 59. Bottom-up and Top-down Approaches for This Report
  • Figure 60. Data Triangulation
  • Figure 61. Key Executives Interviewed
目次

This research report focuses on the Immuno Oncology Assays Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Immuno Oncology Assays Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Immunoassay
    • 1.2.3 Flow Cytometry
    • 1.2.4 PCR
    • 1.2.5 Next Generation Sequencing
  • 1.3 Market by Application
    • 1.3.1 Global Immuno Oncology Assays Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Research
    • 1.3.3 Clinical Diagnostics
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Immuno Oncology Assays Market Perspective (2017-2028)
  • 2.2 Immuno Oncology Assays Growth Trends by Region
    • 2.2.1 Immuno Oncology Assays Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Immuno Oncology Assays Historic Market Size by Region (2017-2022)
    • 2.2.3 Immuno Oncology Assays Forecasted Market Size by Region (2023-2028)
  • 2.3 Immuno Oncology Assays Market Dynamics
    • 2.3.1 Immuno Oncology Assays Industry Trends
    • 2.3.2 Immuno Oncology Assays Market Drivers
    • 2.3.3 Immuno Oncology Assays Market Challenges
    • 2.3.4 Immuno Oncology Assays Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Immuno Oncology Assays Players by Revenue
    • 3.1.1 Global Top Immuno Oncology Assays Players by Revenue (2017-2022)
    • 3.1.2 Global Immuno Oncology Assays Revenue Market Share by Players (2017-2022)
  • 3.2 Global Immuno Oncology Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Immuno Oncology Assays Revenue
  • 3.4 Global Immuno Oncology Assays Market Concentration Ratio
    • 3.4.1 Global Immuno Oncology Assays Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Immuno Oncology Assays Revenue in 2021
  • 3.5 Immuno Oncology Assays Key Players Head office and Area Served
  • 3.6 Key Players Immuno Oncology Assays Product Solution and Service
  • 3.7 Date of Enter into Immuno Oncology Assays Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Immuno Oncology Assays Breakdown Data by Type

  • 4.1 Global Immuno Oncology Assays Historic Market Size by Type (2017-2022)
  • 4.2 Global Immuno Oncology Assays Forecasted Market Size by Type (2023-2028)

5 Immuno Oncology Assays Breakdown Data by Application

  • 5.1 Global Immuno Oncology Assays Historic Market Size by Application (2017-2022)
  • 5.2 Global Immuno Oncology Assays Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Immuno Oncology Assays Market Size (2017-2028)
  • 6.2 North America Immuno Oncology Assays Market Size by Type
    • 6.2.1 North America Immuno Oncology Assays Market Size by Type (2017-2022)
    • 6.2.2 North America Immuno Oncology Assays Market Size by Type (2023-2028)
    • 6.2.3 North America Immuno Oncology Assays Market Share by Type (2017-2028)
  • 6.3 North America Immuno Oncology Assays Market Size by Application
    • 6.3.1 North America Immuno Oncology Assays Market Size by Application (2017-2022)
    • 6.3.2 North America Immuno Oncology Assays Market Size by Application (2023-2028)
    • 6.3.3 North America Immuno Oncology Assays Market Share by Application (2017-2028)
  • 6.4 North America Immuno Oncology Assays Market Size by Country
    • 6.4.1 North America Immuno Oncology Assays Market Size by Country (2017-2022)
    • 6.4.2 North America Immuno Oncology Assays Market Size by Country (2023-2028)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Immuno Oncology Assays Market Size (2017-2028)
  • 7.2 Europe Immuno Oncology Assays Market Size by Type
    • 7.2.1 Europe Immuno Oncology Assays Market Size by Type (2017-2022)
    • 7.2.2 Europe Immuno Oncology Assays Market Size by Type (2023-2028)
    • 7.2.3 Europe Immuno Oncology Assays Market Share by Type (2017-2028)
  • 7.3 Europe Immuno Oncology Assays Market Size by Application
    • 7.3.1 Europe Immuno Oncology Assays Market Size by Application (2017-2022)
    • 7.3.2 Europe Immuno Oncology Assays Market Size by Application (2023-2028)
    • 7.3.3 Europe Immuno Oncology Assays Market Share by Application (2017-2028)
  • 7.4 Europe Immuno Oncology Assays Market Size by Country
    • 7.4.1 Europe Immuno Oncology Assays Market Size by Country (2017-2022)
    • 7.4.2 Europe Immuno Oncology Assays Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Immuno Oncology Assays Market Size (2017-2028)
  • 8.2 Asia-Pacific Immuno Oncology Assays Market Size by Type
    • 8.2.1 Asia-Pacific Immuno Oncology Assays Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Immuno Oncology Assays Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Immuno Oncology Assays Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Immuno Oncology Assays Market Size by Application
    • 8.3.1 Asia-Pacific Immuno Oncology Assays Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Immuno Oncology Assays Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Immuno Oncology Assays Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Immuno Oncology Assays Market Size by Region
    • 8.4.1 Asia-Pacific Immuno Oncology Assays Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Immuno Oncology Assays Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Immuno Oncology Assays Market Size (2017-2028)
  • 9.2 Latin America Immuno Oncology Assays Market Size by Type
    • 9.2.1 Latin America Immuno Oncology Assays Market Size by Type (2017-2022)
    • 9.2.2 Latin America Immuno Oncology Assays Market Size by Type (2023-2028)
    • 9.2.3 Latin America Immuno Oncology Assays Market Share by Type (2017-2028)
  • 9.3 Latin America Immuno Oncology Assays Market Size by Application
    • 9.3.1 Latin America Immuno Oncology Assays Market Size by Application (2017-2022)
    • 9.3.2 Latin America Immuno Oncology Assays Market Size by Application (2023-2028)
    • 9.3.3 Latin America Immuno Oncology Assays Market Share by Application (2017-2028)
  • 9.4 Latin America Immuno Oncology Assays Market Size by Country
    • 9.4.1 Latin America Immuno Oncology Assays Market Size by Country (2017-2022)
    • 9.4.2 Latin America Immuno Oncology Assays Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Immuno Oncology Assays Market Size (2017-2028)
  • 10.2 Middle East & Africa Immuno Oncology Assays Market Size by Type
    • 10.2.1 Middle East & Africa Immuno Oncology Assays Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Immuno Oncology Assays Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Immuno Oncology Assays Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Immuno Oncology Assays Market Size by Application
    • 10.3.1 Middle East & Africa Immuno Oncology Assays Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Immuno Oncology Assays Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Immuno Oncology Assays Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Immuno Oncology Assays Market Size by Country
    • 10.4.1 Middle East & Africa Immuno Oncology Assays Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Immuno Oncology Assays Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Thermo Fischer Scientific
    • 11.1.1 Thermo Fischer Scientific Company Details
    • 11.1.2 Thermo Fischer Scientific Business Overview
    • 11.1.3 Thermo Fischer Scientific Immuno Oncology Assays Introduction
    • 11.1.4 Thermo Fischer Scientific Revenue in Immuno Oncology Assays Business (2017-2022)
    • 11.1.5 Thermo Fischer Scientific Recent Developments
  • 11.2 Roche Diagnostics
    • 11.2.1 Roche Diagnostics Company Details
    • 11.2.2 Roche Diagnostics Business Overview
    • 11.2.3 Roche Diagnostics Immuno Oncology Assays Introduction
    • 11.2.4 Roche Diagnostics Revenue in Immuno Oncology Assays Business (2017-2022)
    • 11.2.5 Roche Diagnostics Recent Developments
  • 11.3 Agilent Technologies
    • 11.3.1 Agilent Technologies Company Details
    • 11.3.2 Agilent Technologies Business Overview
    • 11.3.3 Agilent Technologies Immuno Oncology Assays Introduction
    • 11.3.4 Agilent Technologies Revenue in Immuno Oncology Assays Business (2017-2022)
    • 11.3.5 Agilent Technologies Recent Developments
  • 11.4 Illumina
    • 11.4.1 Illumina Company Details
    • 11.4.2 Illumina Business Overview
    • 11.4.3 Illumina Immuno Oncology Assays Introduction
    • 11.4.4 Illumina Revenue in Immuno Oncology Assays Business (2017-2022)
    • 11.4.5 Illumina Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer